Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1426.80
-11.95 (-0.83%) Cipla - Quaterly Results
Date: 29-07-2022
A decrease in the sales to Rs. 31571.30 millions was observed for the quarter ended June 2022. The sales stood at Rs. 35106.70 millions during the similar quarter previous year.The Net Profit of the company registered a slight decline of -18.33% to Rs. 6440.00 millions from Rs. 7885.10 millions.Operating Profit reported a sharp decline to 9750.60 millions from 11977.80 millions in the corresponding previous quarter.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202206 | 202106 | % Var | 202206 | 202106 | % Var | 202203 | 202103 | % Var | |
| Sales | 31571.30 | 35106.70 | -10.07 | 31571.30 | 35106.70 | -10.07 | 130917.90 | 113027.10 | 15.83 |
| Other Income | 1176.80 | 796.60 | 47.73 | 1176.80 | 796.60 | 47.73 | 6667.00 | 2302.80 | 189.52 |
| PBIDT | 9750.60 | 11977.80 | -18.59 | 9750.60 | 11977.80 | -18.59 | 40331.70 | 32976.90 | 22.30 |
| Interest | 22.10 | 80.00 | -72.38 | 22.10 | 80.00 | -72.38 | 269.30 | 450.70 | -40.25 |
| PBDT | 9728.50 | 11897.80 | -18.23 | 9728.50 | 11897.80 | -18.23 | 40062.40 | 32526.20 | 23.17 |
| Depreciation | 1074.60 | 1139.70 | -5.71 | 1074.60 | 1139.70 | -5.71 | 4600.10 | 4686.20 | -1.84 |
| PBT | 8653.90 | 10758.10 | -19.56 | 8653.90 | 10758.10 | -19.56 | 35462.30 | 27840.00 | 27.38 |
| TAX | 2213.90 | 2873.00 | -22.94 | 2213.90 | 2873.00 | -22.94 | 8568.40 | 7393.50 | 15.89 |
| Deferred Tax | -112.50 | -89.30 | 25.98 | -112.50 | -89.30 | 25.98 | -304.00 | -169.20 | 79.67 |
| PAT | 6440.00 | 7885.10 | -18.33 | 6440.00 | 7885.10 | -18.33 | 26893.90 | 20446.50 | 31.53 |
| Equity | 1613.80 | 1613.20 | 0.04 | 1613.80 | 1613.20 | 0.04 | 1613.60 | 1612.90 | 0.04 |
| PBIDTM(%) | 30.88 | 34.12 | -9.48 | 30.88 | 34.12 | -9.48 | 30.81 | 29.18 | 5.59 |